Trial Information

Summary: A migraine study to find and treat cardiac defect (PFO)for potential relief of migraines.

If you have tried both a beta-blocker(inderal, propranolol) and an anti-epileptic (topomax, depakote)- to prevent migraines and not had good results- you may qualify for this study. We will screen you for a certain cardiac defect and if found to have this then you may be randomized to receive a remedy for the defect to potentially decrease or minimize your migraines.

Patient Inclusion Criteria

  • 18-70 years old
  • 4-14 migraine episodes per month
  • ineffective trial of beta-blocker and anti-epileptic medications to prevent migraines

Patient Exclusion Criteria

  • chronic daily headache
  • fibromyalgia or other chronic pain syndromes

Contact:

Pam Lemme, R.N., B.S.N.
Alpine Clinical Research Center
1000 Alpine Ave., Ste. 200
Boulder, CO 80304
Telephone: 303-443-7229
Email:

Profile Page: Alpine Clinical Research Center, Boulder, CO

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:31:39 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA